cannabinoid

News
marijuana-673846_1920

Progress in neurology for Celgene and GW

It’s been a week notable for developments in neurology medicine, with Celgene exercising an option to buy a potential multiple sclerosis drug, as GW Pharma prepares a filing for a phase 3 e